SavedAdd your journal

Journals / European Oral Research / 2015 / Cilt: 49 - Sayı: 3

ADJUNCTIVE USE OF ANTIBIOTICS IN PERIODONTAL THERAPY

Periodontal Tedavide Kullanılan Antibiyotikler

Ece BARÇA
Ece BARÇA
Emine ÇİFÇİBAŞI
Emine ÇİFÇİBAŞI
Serdar ÇİNTAN
Pages
55–62
Publication Date
2015-10-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The points discussed are the mode of antibiotic action, susceptible periodontal pathogens, antibiotic dosage, antibiotic use in treatment of periodontal disease, and mechanism of bacterial resistance to each antibiotic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Periodontal diseases are infectious diseases with a mixed microbial aetiology and marked inflammatory response leading to destruction of underlying tissue.
📊
Key Findings & Data:Periodontal therapy aims to eliminate pathogens associated with the disease and attain periodontal health.
💡
Conclusion & Impact:The points discussed are the mode of antibiotic action, susceptible periodontal pathogens, antibiotic dosage, antibiotic use in treatment of periodontal disease, and mechanism of bacterial resistance to each antibiotic.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Sistemik antibiyotikler · periodontal hastalık · tedavi

Abstract

Periodontal diseases are infectious diseases with a mixed microbial aetiology and marked inflammatory response leading to destruction of underlying tissue. Periodontal therapy aims to eliminate pathogens associated with the disease and attain periodontal health. Periodontitis is generally treated by nonsurgical mechanical debridement and regular periodontal maintenance care. Periodontal surgery may be indicated for some patients to improve access to the root surface; however, mechanical debridement alone may not be helpful in all cases. In such cases, adjunctive systemic antibiotic therapy remains the treatment of choice. It can reach microorganisms at the base of the deep periodontal pockets and furcation areas via serum, and also affects organisms residing within gingival epithelium and connective tissue. This review aims to provide an update on clinical issues regarding when and how to prescribe systemic antibiotics in periodontal therapy. The points discussed are the mode of antibiotic action, susceptible periodontal pathogens, antibiotic dosage, antibiotic use in treatment of periodontal disease, and mechanism of bacterial resistance to each antibiotic.

Özet

Periodontal hastalıklar periodontal dokuların doku yıkımına yol açan, karışık mikrobiyal etyolojisi ve belirgin inflamatuvar yanıt ile karakterize enfeksiyöz hastalıklardır. Periodontal tedavinin amacı, hastalık ile ilişkili patojenlerin ortadan kaldırılması ve periodontal sağlığın elde edilmesidir. Periodontitis tedavisi genellikle cerrahi olmayan mekanik debridman ve düzenli periodontal bakım ile yapılır. Periodontal cerrahi bazı hastalarda kök yüzeyine erişimi artırmak için endike olabilir; ancak, yalnız mekanik debridman tüm durumlarda yarar sağlamayabilir. Bu tür durumlarda, ilave antibiyotik tedavisi düşünülebilir. Böylece, serum ile derin periodontal cepler ve furkasyon alanlarının tabanında mikroorganizmalara ulaşım ve aynı zamanda dişeti epiteli ve bağ dokusu içinde bulunan organizmalara etki sağlanır. Bu derlemede, periodontal hastalıkta ne zaman ve hangi durumlarda sistemik antibiyotik reçete edilmesi gerektiği üzerine güncel klinik yaklaşımlar değerlendirilmiştir. Etki mekanizmaları, duyarlı periodontal patojenler, dozaj, periodontal hastalıkların tedavisinde kullanımı ve her antibiyotik için bakteri direnç mekanizması tartışılmıştır.

🔖

Cite This Article

BARÇA, E., BARÇA, E., ÇİFÇİBAŞI, E., ÇİFÇİBAŞI, E., ÇİNTAN, S. (2015). ADJUNCTIVE USE OF ANTIBIOTICS IN PERIODONTAL THERAPY. European Oral Research, Cilt: 49 - Sayı: 3, 55–62. https://ajindex.com/articles/242986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Saglie FR, Carranza FA Jr, Newman MG, Cheng L, Lewin KJ. Identification of tissue-invading bacteria in human periodontal disease. J Periodontol Res 1982;17(5):452–455. Marsh PD. Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol 2005;32(Suppl 6):7–15.
  2. Eick S, Seltmann T, Pfister W. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. J Clin Periodontol 2004;31(5):376–383.
  3. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43(11):5721-5732. Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996;10:79-88.
  4. Slots J, Rams TE. New views on periodontal microbiota in special patient categories. J Clin Periodontol 1991;18(6):411-420.
  5. Schenkein HA, Van Dyke TE. Early-onset periodontitis: systemic aspects of etiology and pathogenesis. Periodontol 2000 1994;6(1):7-25.
  6. Johnson BD, Engel D. Acute necrotizing ulcerative gingivitis. A review of diagnosis, etiology and treatment. J Periodontol 1986;57(3):141-150.
  7. Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990;17(7 Pt 2):479-493.
  8. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8(1):115-181. Pallasch TJ. Pharmacokinetic principles of antimicrobial therapy. Periodontol 2000 1996;10(1):5-11. van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontitis. Periodontol 2000 1996;10(1):45-78.
  9. Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000 2002;28(1):12-55.
  10. Van Winkelhoff AJ, Van der Velden U, Clement M, De Graaff J. Intra-oral distribution of black-pigmented Bacteriodes species in periodontitis patients. Oral Microbiol Immunol 1988;3(2):83-85. Walker CB. Selected antimicrobial agents: mechanism of action, side effects and drug interactions. Periodontol 2000 1996;10(1):12-28.
  11. Loesche WJ, Grossman N, Giordano J. Metronidazole in periodontitis (IV). The effect of patient compliance on treatment parameters. J Clin Periodontol 1993;20(2):96-104. Pavicic MJ, van Winkelhoff AJ, de Graaff J. In vitro susceptibilities of Actinobacilus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992;36(12):2634-2638.
  12. Slots J, Schonfeld SE. Actinobacillus actinomycetemcomita